Geode Capital Management LLC increased its stake in shares of Houlihan Lokey, Inc. (NYSE:HLI - Free Report) by 2.8% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 970,559 shares of the financial services provider's stock after buying an additional 26,564 shares during the quarter. Geode Capital Management LLC owned about 1.40% of Houlihan Lokey worth $153,405,000 at the end of the most recent reporting period.
Other hedge funds have also recently added to or reduced their stakes in the company. Earnest Partners LLC grew its holdings in shares of Houlihan Lokey by 1.9% during the 2nd quarter. Earnest Partners LLC now owns 3,273,818 shares of the financial services provider's stock worth $441,507,000 after purchasing an additional 62,314 shares in the last quarter. Kayne Anderson Rudnick Investment Management LLC lifted its position in Houlihan Lokey by 1.3% during the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 3,087,898 shares of the financial services provider's stock worth $416,434,000 after purchasing an additional 38,155 shares during the period. State Street Corp grew its stake in Houlihan Lokey by 1.3% during the third quarter. State Street Corp now owns 1,615,467 shares of the financial services provider's stock worth $255,276,000 after buying an additional 21,106 shares in the last quarter. Sei Investments Co. increased its holdings in Houlihan Lokey by 6.2% in the 2nd quarter. Sei Investments Co. now owns 776,335 shares of the financial services provider's stock valued at $104,697,000 after buying an additional 45,205 shares during the period. Finally, Eagle Asset Management Inc. raised its position in shares of Houlihan Lokey by 23.6% in the 3rd quarter. Eagle Asset Management Inc. now owns 693,109 shares of the financial services provider's stock valued at $109,525,000 after buying an additional 132,516 shares in the last quarter. Institutional investors own 78.07% of the company's stock.
Houlihan Lokey Stock Down 0.8 %
Shares of NYSE HLI traded down $1.51 during midday trading on Tuesday, reaching $178.03. 375,703 shares of the company were exchanged, compared to its average volume of 320,514. The stock's 50-day moving average price is $178.29 and its 200-day moving average price is $157.26. The stock has a market cap of $12.37 billion, a P/E ratio of 36.41 and a beta of 0.67. Houlihan Lokey, Inc. has a one year low of $112.17 and a one year high of $192.10.
Houlihan Lokey (NYSE:HLI - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $1.46 earnings per share for the quarter, topping analysts' consensus estimates of $1.31 by $0.15. The business had revenue of $574.96 million for the quarter, compared to analyst estimates of $537.93 million. Houlihan Lokey had a return on equity of 19.29% and a net margin of 15.77%. Houlihan Lokey's quarterly revenue was up 23.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS. On average, equities research analysts anticipate that Houlihan Lokey, Inc. will post 5.74 EPS for the current year.
Houlihan Lokey Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Sunday, December 15th. Investors of record on Monday, December 2nd were issued a $0.57 dividend. The ex-dividend date of this dividend was Monday, December 2nd. This represents a $2.28 dividend on an annualized basis and a yield of 1.28%. Houlihan Lokey's dividend payout ratio (DPR) is presently 46.63%.
Analyst Upgrades and Downgrades
HLI has been the topic of several analyst reports. Wells Fargo & Company increased their price target on shares of Houlihan Lokey from $157.00 to $180.00 and gave the stock an "underweight" rating in a research report on Thursday, December 12th. Morgan Stanley downgraded Houlihan Lokey from an "equal weight" rating to an "underweight" rating and raised their target price for the company from $171.00 to $200.00 in a report on Monday, December 9th. StockNews.com cut Houlihan Lokey from a "buy" rating to a "hold" rating in a report on Wednesday, November 20th. Finally, UBS Group upped their price objective on Houlihan Lokey from $170.00 to $190.00 and gave the stock a "buy" rating in a research report on Tuesday, October 8th. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the company. According to MarketBeat, Houlihan Lokey currently has an average rating of "Hold" and a consensus target price of $170.60.
Read Our Latest Research Report on HLI
Insider Buying and Selling
In other Houlihan Lokey news, Director Gillian Beth Zucker sold 200 shares of the company's stock in a transaction dated Monday, October 14th. The stock was sold at an average price of $168.08, for a total value of $33,616.00. Following the sale, the director now owns 6,601 shares in the company, valued at approximately $1,109,496.08. The trade was a 2.94 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 23.68% of the stock is owned by corporate insiders.
Houlihan Lokey Profile
(
Free Report)
Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.
Read More
Before you consider Houlihan Lokey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Houlihan Lokey wasn't on the list.
While Houlihan Lokey currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.